# Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease

> **NCT01810185** · PHASE2 · WITHDRAWN · sponsor: **Santa Barbara Cottage Hospital**

## Conditions studied

- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** Low dose naltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01810185
- **Lead sponsor:** Santa Barbara Cottage Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Low patient enrollment
- **Last updated:** 2014-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01810185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01810185, "Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01810185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*